Concerns Over Funding Cuts to Anti-Malaria Efforts

Reduced contributions from affluent nations to an anti-malaria initiative may lead to a resurgence of the disease, potentially resulting in millions of deaths and significant economic losses by the decade’s end, according to a new analysis.

The battle against malaria is facing fresh challenges. There’s the impact of extreme weather and ongoing humanitarian crises that are increasing the number of people at risk. Plus, there’s growing resistance to both insecticides and antimalarial medications, as highlighted in the report.

Gareth Jenkins from Malaria No More UK remarked that slashing funding “risks the deadliest resurgence we’ve ever seen.” The situation is indeed alarming.

Analysts indicated that sub-Saharan Africa would bear a heavy cost. In response, the region’s leaders are urging the G7 to sustain their investments. They’ve also reached out to the private sector and wealthy individuals, suggesting that effective malaria control could drive economic growth and enhance trade.

Joy Phumaphi from the African Leaders Malaria Alliance (ALMA), which partnered with Malaria No More UK for this study, emphasized that “African countries are stepping up,” but called for global support. She stressed that everyone has a role to play in putting an end to malaria.

The report estimates the effects of funding cuts on the Global Fund to Fight AIDS, TB, and Malaria, which is currently soliciting donations for costs expected between 2027 and 2029. This fund supplies nearly 60% of international financing for malaria control measures, including mosquito nets and preventive medications.

If contributions were to drop by 20% from previous rounds, researchers predict an additional 33 million malaria cases and 82,000 deaths, along with a GDP loss of about $5.14 billion (£3.83 billion) by 2030.

Unfortunately, funding reductions appear imminent. Just recently, Germany pledged $1 billion to the fund, which is 23% less than their prior commitment. Reports suggest the UK government is considering a similar reduction, potentially 20% less than what they had previously promised, although they say a final decision hasn’t been made yet.

Should there be a total collapse in funding for preventive malaria measures, the consequences could be dire. The report estimates this could lead to 525 million more cases, 990,000 additional deaths, and a staggering $83 billion loss in GDP. Alarmingly, about 750,000 of those deaths would involve children under five, which would be a catastrophic loss for a generation.

On the brighter side, if the Global Fund receives the full $18 billion it’s requesting, the potential benefits could be significant, including a $230 billion increase in GDP, 865 million fewer cases, and 1.86 million fewer deaths.

Phumaphi mentioned notable increases in budget allocations for health and specifically malaria in several African nations since the start of the year, which is promising. However, there’s a pressing need to recognize the scale of the challenge and how much funding is truly necessary for these countries to catch up.

Countries in Africa, already burdened by debt and the lingering effects of COVID-19, are grappling not only with malaria but also a rise in non-communicable diseases like diabetes and cancer.

Phumaphi expressed concern over the potential for donor countries to pledge less than before, but she appreciated commitments like Germany’s, noting that “a billion is quite a substantial amount.”

She is hopeful that wealthy individuals and the private sector will help fill the funding void. The Nigerian businessman Aliko Dangote urged others to join in, stating that malaria isn’t just a health crisis but also a significant obstacle to Africa’s growth and business potential.

Malaria affects GDP through various factors, including interrupted education, employee absences, and its impact on tourism and agriculture.